Advertisement
Screener

LIPOCINE INC. (LPCN) Proceeds from Royalties Received

2.8 / 5 stars · 68/120 Roast Me

LIPOCINE INC. Proceeds from Royalties Received

LIPOCINE INC. (LPCN) reported Proceeds from Royalties Received of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromRoyaltiesReceived · last filed 2021-03-11

  • LIPOCINE INC. proceeds from royalties received for the quarter ending 2019-12-31 was $0.00.
  • LIPOCINE INC. proceeds from royalties received for the quarter ending 2019-09-30 was $165.00K.
  • LIPOCINE INC. proceeds from royalties received for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
  • LIPOCINE INC. proceeds from royalties received for fiscal 2019 was $165.00K.
Period endProceeds from Royalties Received 3 monthProceeds from Royalties Received 6 monthProceeds from Royalties Received 9 monthProceeds from Royalties Received 12 month
2020-12-31$0.00
10-K · filed 2021-03-11
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
$165.00K
derived: sum of 2 quarters · filed 2021-03-11
$165.00K
10-K · filed 2021-03-11
2019-09-30$165.00K
10-Q · filed 2020-11-10
$165.00K
10-Q · filed 2020-11-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Rocket One Inc. (RKTO)United States$0.019B
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03